Clinical trial

Immune-checkpoint Blockade After Partial Breast Irradiation by Pembrolizumab in Early TNBC

NCT07011823

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-07-16

PhasePHASE2

Study timeline

Study start (estimated)2025-07-16Date precision: day

Registry last updated2025-06-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Triple-Negative Breast Neoplasmunresolved

Interventions

Partial breast-irradiationRADIATION

Sponsors & collaborators

Gangnam Severance Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07011823 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.